John Chiminski

Chair & Chief Executive Officer at Catalent, Inc.

John Chiminski

John Chiminski

Chair & Chief Executive Officer at Catalent, Inc.

Overview
Career Highlights

Juniper Pharmaceuticals, Inc.
Catalent Pharma Solutions, Inc.
Catalent, Inc.

RelSci Relationships

1464

Number of Boards

6

Birthday

1964

Age

57

Relationships
RelSci Relationships are individuals John Chiminski likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer & Director at CC Neuberger Principal Holdings II

Relationship likelihood: Strong

President at Jewish Board of Family & Children's Services, Inc.

Relationship likelihood: Strong

Senior Vice President & Chief Financial Officer at Catalent, Inc.

Relationship likelihood: Strong

Senior Managing Director, Private Equity at The Blackstone Group, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at REV Holdings LLC

Relationship likelihood: Strong

Chief Scientific Officer at Catalent Pharma Solutions, Inc.

Relationship likelihood: Strong

Operations Team Member at The Blackstone Group, Inc.

Relationship likelihood: Strong

Senior Advisor at Astor Place Holdings

Relationship likelihood: Strong

Head, Quality, Product Development & Regulatory Affairs at Catalent Pharma Solutions, Inc.

Relationship likelihood: Strong

Former Chairman & Chief Executive Officer at NuVasive Inc.

Relationship likelihood: Strong

Paths to John Chiminski
Potential Connections via
Relationship Science
You
John Chiminski
Chair & Chief Executive Officer at Catalent, Inc.
Education
Master's Management
Class of 1996

The Kellogg School of Management (The Kellogg School or Kellogg) is the business school of Northwestern University in Evanston, Illinois, with additional campuses in downtown Chicago, Illinois and Miami, Florida. Kellogg offers full-time, part-time, and executive programs, and partners with schools in China, France/Singapore, India, Hong Kong, Israel, Germany, Canada, and Thailand.Founded in 1908 in downtown Chicago as a part-time evening program, the school was chartered to educate business leaders with "good moral character.

MS Electrical Engineering
Class of 1987

Purdue University, located in West Lafayette, Indiana, is the flagship university of the six-campus Purdue University system. Purdue was founded on May 6, 1869, as a land-grant university when the Indiana General Assembly, taking advantage of the Morrill Act, accepted a donation of land and money from Lafayette businessman John Purdue to establish a college of science, technology, and agriculture in his name. The first classes were held on September 16, 1874, with six instructors and 39 students. The university was founded with the gift of $150,000 from John Purdue, a Lafayette business leader and philanthropist, along with $50,000 from Tippecanoe County, and 150 acres (0.6 km²) of land from Lafayette residents in support of the project. In 1869, it was decided that the new school would be built near the city of Lafayette and established as Purdue University, in the name of the institution’s principal benefactor. The West Lafayette campus offers more than 200 majors for undergraduates, over 70 master’s and doctoral programs, and professional degrees in pharmacy and veterinary medicine. In addition, Purdue has 18 intercollegiate sports teams and more than 850 student organizations. Today, Purdue is a member of the Big Ten Conference. Purdue enrolls the second largest student body of any university in Indiana as well as the fourth largest international student population of any university in the United States.

BS in Electrical Engineering
Class of 1986

Michigan State University (MSU) is a public research university located in East Lansing, Michigan, United States and is the first land-grant institution that was created to serve as a model for future land-grant colleges in the country under the 1862 Morrill Act. Michigan State has been labeled one of the "Public Ivies," a publicly funded university considered as providing a quality of education comparable to those of the Ivy League. Following the introduction of the Morrill Act, the college became coeducational and expanded its curriculum beyond agriculture. Today, MSU is the ninth-largest university in the United States, with 47,800 students and 2,954 faculty members.

Career History
President & Chief Executive Officer
2009 - Current

Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ.

President & Chief Executive Officer
2007 - 2009
Chair & Chief Executive Officer
2009 - Current

Catalent, Inc. operates as a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale manufacturing of oral solid dose forms for pharmaceutical and consumer health markets, and supporting ancillary services. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing; formulation, development, and manufacturing for parenteral dose forms, which include prefilled syringes, vials, and cartridges; and analytical development and testing services for large molecules. The Oral and Speciality Delivery segment provides advanced formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ.

Boards & Committees
Chairman, Board of Directors
2009 - Current

Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ.

Chair, Board of Directors
2009 - Current

Catalent, Inc. operates as a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale manufacturing of oral solid dose forms for pharmaceutical and consumer health markets, and supporting ancillary services. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing; formulation, development, and manufacturing for parenteral dose forms, which include prefilled syringes, vials, and cartridges; and analytical development and testing services for large molecules. The Oral and Speciality Delivery segment provides advanced formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ.

Director
Prior - 2015

DJO Finance LLC develops, manufactures and distributes medical devices with a products used for rehabilitation, pain management and physical therapy. The company was founded in 2006 and is headquartered in Vista, CA.

Trustee
Tenure Unconfirmed

Founded in 1997, the HealthCare Institute of New Jersey (HINJ) is a trade association for the research-based biopharmaceutical and medical technology industry in New Jersey. HINJ serves as a unified voice for New Jersey’s life sciences industry and seeks to build awareness of this industry’s impact on New Jersey’s quality of life and economic well-being.

Political Donations
Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by John Chiminski. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of John Chiminski's profile does not indicate a business or promotional relationship of any kind between RelSci and John Chiminski.